Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pedro Salinas
Observed name:
P. Salinas
Institutions:
Hospital Universitario Sanitas La Zarzuela,
Sanitas (Spain)
Observed institutions:
Universidad Complutense de Madrid,
Hospital de Sant Pau,
Clinica Universidad de Navarra,
Hospital de Cruces,
Hospital Universitario Sanitas La Zarzuela,
Sanitas (Spain)
show all 6
ORCID:
0000-0002-9861-9068
Observed ORCID:
0000-0002-9861-9068
OpenAlex ID:
A5108379030
Brain metastases from lung cancer responding to erlotinib: the importance ofEGFRmutation
2010
·
R. Porta
, J.M. Sánchez-Torres
, et al.
·
European Respiratory Journal
·
332
PDF
Diet and colorectal cancer
2015
·
Raul Baena
, Pedro Salinas
·
Maturitas
·
264
Lack of platelet-activating factor release on acute myocardial ischemia in the isolated interventricular septum of rabbit heart
1995
·
Pedro Salinas
, M.Dolores Perez
, et al.
·
European Journal of Pharmacology Environmental Toxicology and Pharmacology
·
5
67 Phase II activity of gemcitabine + cisplatin in advanced non-small cell lung cancer (NSCLC)
1997
·
M. Gonzalez-Barón
, M. Gracia
, et al.
·
Lung Cancer
·
4
Erlotinib in patients with advanced squamous cell carcinoma of the lung
2006
·
A. Gúrpide
, B. Massutí
, et al.
·
Journal of Clinical Oncology
·
3
Ultrastructural Evidence of the Protective Effect of Na+/H+ Exchange Inhibition on the in vitro Damage Induced by Ischaemia Reperfusion in the Interventricular Septum of the Rabbit Heart
2000
·
Pedro Salinas
, Pablo Gil-Loyzaga
, et al.
·
Pharmacology & Toxicology
·
3
PDF
Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias
1991
·
Pedro Salinas
, Santos Barrigón
·
European Journal of Pharmacology
·
3
Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
·
Clinical Cancer Research
·
2
Supplementary Figure S2 from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
Supplementary Figure S4 from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
Supplementary Figure S3 from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
Supplementary Figure S5 from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
Data from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
Supplementary Table S1 from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
Supplementary Figure S1 from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026
·
Laura Visa
, Jordi Badia-Ramentol
, et al.
PD-10 Comprehensive circulating tumor (ct) DNA NGS for molecular profiling in advanced cholangiocarcinoma
2022
·
L. Visa
, T. Sauri
, et al.
·
Annals of Oncology
Toxicity of prolonged treatment with eribulin (E) in metastatic breast cancer (MBC) patients: Results of the EXTER study.
2015
·
Francisco Ayala
, Margarita Feijoo
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
17
Citation count:
616
H-index:
4
I10-index:
2
Year
Topic
Type